Allogeneic transplant following brentuximab vedotin in patients with relapsed or refractory Hodgkin lymphoma and systemic anaplastic large cell lymphoma.
Saved in:
| Title: | Allogeneic transplant following brentuximab vedotin in patients with relapsed or refractory Hodgkin lymphoma and systemic anaplastic large cell lymphoma. |
|---|---|
| Authors: | Illidge, Tim1 (AUTHOR) tillidge@picr.man.ac.uk, Bouabdallah, Reda2 (AUTHOR), Chen, Robert3 (AUTHOR), Gopal, Ajay K.4 (AUTHOR), Moskowitz, Craig H.5 (AUTHOR), Ramchandren, Radhakrishnan6 (AUTHOR), Shustov, Andrei R.4 (AUTHOR), Tilly, Herve7 (AUTHOR), Trippett, Tanya M.5 (AUTHOR), Gibb, Adam8 (AUTHOR), Grove, Laurie E.9 (AUTHOR), Advani, Ranjana10 (AUTHOR) |
| Source: | Leukemia & Lymphoma. Mar2015, Vol. 56 Issue 3, p703-710. 8p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
